170 related articles for article (PubMed ID: 35172473)
1. Correlation-based and feature-driven mutation signature analyses to identify genetic features associated with DNA mutagenic processes in cancer genomes.
Jeong HY; Yoo J; Kim H; Kim TM
Genomics Inform; 2021 Dec; 19(4):e40. PubMed ID: 35172473
[TBL] [Abstract][Full Text] [Related]
2. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
Farmanbar A; Firouzi S; Kneller R; Khiabanian H
J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
[TBL] [Abstract][Full Text] [Related]
3. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
[TBL] [Abstract][Full Text] [Related]
4. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
[TBL] [Abstract][Full Text] [Related]
5. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
Phillips DH
DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
[TBL] [Abstract][Full Text] [Related]
7. Mutational signatures in squamous cell carcinoma of the lung.
Osoegawa A; Takada K; Okamoto T; Sato S; Nagahashi M; Tagawa T; Tsuchida M; Oki E; Okuda S; Wakai T; Mori M
J Thorac Dis; 2021 Feb; 13(2):1075-1082. PubMed ID: 33717580
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
9. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
Patel J; den Breems NY; Tuluc M; Johnson J; Curry JM; South AP; Cho RJ
J Med Case Rep; 2021 Apr; 15(1):252. PubMed ID: 33926553
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genomic characterization of mutational signatures across human cancers.
Liao J; Bai J; Pan T; Zou H; Gao Y; Guo J; Xu Q; Xu J; Li Y; Li X
Int J Cancer; 2023 Apr; 152(8):1613-1629. PubMed ID: 36533638
[TBL] [Abstract][Full Text] [Related]
11. The topography of mutational processes in breast cancer genomes.
Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
[TBL] [Abstract][Full Text] [Related]
12. Influence network model uncovers relations between biological processes and mutational signatures.
Amgalan B; Wojtowicz D; Kim YA; Przytycka TM
Genome Med; 2023 Mar; 15(1):15. PubMed ID: 36879282
[TBL] [Abstract][Full Text] [Related]
13. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
[TBL] [Abstract][Full Text] [Related]
14. The shaping of cancer genomes with the regional impact of mutation processes.
Lee SY; Wang H; Cho HJ; Xi R; Kim TM
Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
[TBL] [Abstract][Full Text] [Related]
15. Mutation Signatures Including APOBEC in Cancer Cell Lines.
Jarvis MC; Ebrahimi D; Temiz NA; Harris RS
JNCI Cancer Spectr; 2018 Jan; 2(1):. PubMed ID: 29888758
[TBL] [Abstract][Full Text] [Related]
16. Gaining insights into relevance across cancers based on mutation features of TP53 gene.
Mei Y; Liang D; Wang T; Yu D
Biochem Biophys Rep; 2021 Dec; 28():101165. PubMed ID: 34786492
[TBL] [Abstract][Full Text] [Related]
17. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
18. APOBEC-Induced Mutagenesis in Cancer.
Mertz TM; Collins CD; Dennis M; Coxon M; Roberts SA
Annu Rev Genet; 2022 Nov; 56():229-252. PubMed ID: 36028227
[TBL] [Abstract][Full Text] [Related]
19. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
20. Breaking bad: The mutagenic effect of DNA repair.
Chen J; Furano AV
DNA Repair (Amst); 2015 Aug; 32():43-51. PubMed ID: 26073774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]